These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2949828)

  • 1. Suppressor cell activity in melanoma-draining lymph nodes.
    Hoon DS; Bowker RJ; Cochran AJ
    Cancer Res; 1987 Mar; 47(6):1529-33. PubMed ID: 2949828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concanavalin A-inducible suppressor cells in regional lymph nodes of cancer patients.
    Catalona WJ; Ratliff TL; McCool RE
    Cancer Res; 1979 Nov; 39(11):4372-7. PubMed ID: 159124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocytes from lymph nodes at different distances from human melanoma vary in their capacity to inhibit/enhance tumor cell growth in vitro.
    Farzad Z; McBride WH; Ogbechi H; Asnong-Holthoff C; Morton DL; Cochran AJ
    Melanoma Res; 1997 Aug; 7 Suppl 2():S59-65. PubMed ID: 9578418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variations in functional immunocompetence of individual tumor-draining lymph nodes in humans.
    Hoon DS; Korn EL; Cochran AJ
    Cancer Res; 1987 Mar; 47(6):1740-4. PubMed ID: 3493068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of cellular immune response against autologous human melanoma. I. Evidence for cell-mediated suppression of in vitro cytotoxic immune response.
    Mukherji B; Wilhelm SA; Guha A; Ergin MT
    J Immunol; 1986 Mar; 136(5):1888-92. PubMed ID: 2419418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of cellular immune response against autologous human melanoma. II. Mechanism of induction and specificity of suppression.
    Mukherji B; Nashed AL; Guha A; Ergin MT
    J Immunol; 1986 Mar; 136(5):1893-8. PubMed ID: 2419419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A continued evaluation of the experimental conditions of a Con A-induced suppressor test system.
    Davidsen B; Kristensen E
    Acta Pathol Microbiol Immunol Scand C; 1983 Aug; 91(4):283-91. PubMed ID: 6227202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immune reactivities of lymphocytes from peripheral blood, regional lymph nodes and tumor-infiltrating lymphocytes in breast cancer].
    Hisamatsu K; Toge T; Yanagawa E; Hamada Y; Seto Y; Yamada H; Toi M; Hattori T
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2555-61. PubMed ID: 2943228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antithyroid drugs on Con A-induced suppressor cell activity.
    Okabe N; Mori R; Miake S; Inoue K
    J Clin Lab Immunol; 1984 Apr; 13(4):167-9. PubMed ID: 6234399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of suppressor-cell activity by cyclophosphamide in patients with malignant melanoma.
    Livingston PO; Cunningham-Rundles S; Marfleet G; Gnecco C; Wong GY; Schiffman G; Enker WE; Hoffman MK
    J Biol Response Mod; 1987 Aug; 6(4):392-403. PubMed ID: 2957470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune status in Crohn's disease. VI. Immunoregulation evaluated by multiple, distinct T-suppressor cell assays of lymphocyte proliferation, and by enumeration of immunoregulatory T-lymphocyte subsets.
    Auer IO; Röder A; Fröhlich J
    Gastroenterology; 1984 Jun; 86(6):1531-43. PubMed ID: 6232166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative ability to provide help: an explanation for Con A-induced suppression.
    Farrant J; Newton C
    Clin Exp Immunol; 1981 Sep; 45(3):504-13. PubMed ID: 6461448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficient concanavalin-A-induced suppressor cell activity in women with untreated breast cancer.
    Gupta S; Cunningham-Rundles S
    J Clin Lab Immunol; 1982 Dec; 9(3):159-61. PubMed ID: 6220154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Con A suppressor cell assay: a further characterization.
    Meroni PL; Balestrieri G; Barcellini W; DeBartolo G; Fenini G; Tincani A; Zanussi C
    J Clin Lab Immunol; 1983 Mar; 10(3):159-63. PubMed ID: 6221109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression by melanoma cells as a factor in the generation of metastatic disease.
    Cochran AJ; Wen DR; Farzad Z; Stene MA; McBride W; Lana AM; Hoon DS; Morton DL
    Anticancer Res; 1989; 9(4):859-64. PubMed ID: 2683997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zoned immune suppression of lymph nodes draining malignant melanoma: histologic and immunohistologic studies.
    Cochran AJ; Pihl E; Wen DR; Hoon DS; Korn EL
    J Natl Cancer Inst; 1987 Mar; 78(3):399-405. PubMed ID: 3469453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional and surface phenotype study of lymphocyte subsets in peripheral blood and lymph nodes of breast cancer patients.
    Mantovani G; Serri FG; Macciò A; Castelli P; Benedetti P; Scambia G; Santus S; Paderi R; Murtas MG; Ferreli A
    Cancer Detect Prev; 1989; 13(5-6):323-32. PubMed ID: 2743354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concanavalin A triggers T lymphocytes by directly interacting with their receptors for activation.
    Palacios R
    J Immunol; 1982 Jan; 128(1):337-42. PubMed ID: 6459373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of DNA synthesis by con A-activated human lymphocytes: role of monocytes in con A-induced suppression.
    Kallenberg CG; de Gast GC; The TH
    Clin Exp Immunol; 1980 Sep; 41(3):583-90. PubMed ID: 6449339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro X-ray irradiation of human peripheral blood T lymphocytes enhances suppressor function.
    Ogawa H; Tsunematsu T
    Clin Exp Immunol; 1983 Aug; 53(2):444-50. PubMed ID: 6224611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.